Who
Wagner M. Zago
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Prothena Corporation.
In numbers
- Trades disclosed
- 57
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $8.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jun 2017
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | —51,000 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code D | $437K51,000 at $8.56 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —51,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —51,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | —51,000 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code D | $437K51,000 at $8.56 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 28 Jul 2025filed 30 Jul 2025 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,500 at $0.00 | filing |
| 27 Feb 2024filed 29 Feb 2024 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 2 Aug 2023filed 2 Aug 2023 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 2 Aug 2023filed 2 Aug 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | $49K4,000 at $12.15 | filing |
| 2 Aug 2023filed 2 Aug 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Sold | $253K3,771 at $66.98 | filing |
| 2 Aug 2023filed 2 Aug 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Sold | $16K229 at $68.07 | filing |
| 5 Jul 2023filed 5 Jul 2023 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 5 Jul 2023filed 5 Jul 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | $49K4,000 at $12.15 | filing |
| 5 Jul 2023filed 5 Jul 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Sold | $203K2,991 at $67.98 | filing |
| 5 Jul 2023filed 5 Jul 2023 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Sold | $69K1,009 at $68.69 | filing |
| 7 Jun 2023filed 7 Jun 2023 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
News
Prothena Corporation plc (PRTA) – What Are Analysts Saying About This Stock?PRTA · dailypolitical.com · 20 Oct 2026Prothena (NASDAQ:PRTA) Major Shareholder William Scully Buys 100,000 Shares of Company StockPRTA · dailypolitical.com · 15 Oct 2026Prothena (NASDAQ:PRTA) vs. Kyntra Bio (NASDAQ:KYNB) Financial ReviewPRTA · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Wagner M. Zago; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.